The Latest Breaking News from AstraZeneca

Women with HER2-low incurable secondary disease in Scotland currently have access, while others across the UK do not

The former pharma laggard is in a race with Shell to be the first FTSE 100 stock to be valued at £200bn

A group of doctors under the banner of Awaken India Movement (AIM) have raised concerns over the side effects of Covishield vaccine in the wake of pharmaceutical giant AstraZeneca admitting in a U.K. court that its vaccine can cause blood clots in rare cases.

There is another segment of the pharma industry that is as hot as weight-loss drugs: antibody-drug conjugates, or ADCs. These treatments will, in the near future, replace conventional chemotherapy, thanks to fewer side effects for patients. Even a partial replacement for chemotherapy could make it a $140 billion market -…

Although dogged by controversy, the firm’s coronavirus jab saved the lives of millions and helped avert humanitarian crises in nations unable to access costly alternatives

Richard Daly has watched Catalyst Pharmaceuticals transform. Now, as the company's new CEO, he has some metamorphic ideas of his own.

Doctors express concern over Covishield vaccine safety due to potential blood clot side effects, urging government review and action.

New research suggests chemicals in flavoured vapes could be highly toxic when heated.

AstraZeneca withdraws Vaxzevria vaccine due to decreased demand from newer, more effective mRNA vaccines. Strategic shift in global vaccination landscape.